| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |